Murphy Andrew J's Form 4 filing
Regeneron Pharmaceuticals, Inc. (REGN) · filed Nov 15, 2023
- Accession no.
- 0001968202-23-000042
- Filed
- Nov 15, 2023
- Trade date
- Nov 13-14, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 13 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.19M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Murphy Andrew JCIK 0001796226 | Officer (EVP Research) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2023 | Common Stock | MOption exerciseAcquired | +20,000 | $270.43 | +$5,408,600 | 79,421 | Direct | |
| Nov 13, 2023 | Common Stock | FTax withholdingDisposed | −13,508 | $795.69 | −$10,748,180.52 | 65,913 | Direct | |
| Nov 14, 2023 | Common Stock | SSaleDisposed | −752 | $794.57F2 | −$597,516.64 | 65,161 | Direct | |
| Nov 14, 2023 | Common Stock | SSaleDisposed | −347 | $795.38F3 | −$275,996.86 | 64,814 | Direct | |
| Nov 14, 2023 | Common Stock | SSaleDisposed | −204 | $797.79F4 | −$162,749.16 | 64,610 | Direct | |
| Nov 14, 2023 | Common Stock | SSaleDisposed | −1,614 | $798.63F5 | −$1,288,988.82 | 62,996 | Direct | |
| Nov 14, 2023 | Common Stock | SSaleDisposed | −1,601 | $799.48F6 | −$1,279,967.48 | 61,395 | Direct | |
| Nov 14, 2023 | Common Stock | SSaleDisposed | −382 | $800.55F7 | −$305,810.1 | 61,013 | Direct | |
| Nov 14, 2023 | Common Stock | SSaleDisposed | −877 | $801.56F8 | −$702,968.12 | 60,136 | Direct | |
| Nov 14, 2023 | Common Stock | SSaleDisposed | −347 | $802.63F9 | −$278,512.61 | 59,789 | Direct | |
| Nov 14, 2023 | Common Stock | SSaleDisposed | −330 | $803.38F10 | −$265,115.4 | 59,459 | Direct | |
| Nov 14, 2023 | Common Stock | SSaleDisposed | −19 | $804.89 | −$15,292.91 | 59,440 | Direct | |
| Nov 14, 2023 | Common Stock | SSaleDisposed | −19 | $805.00 | −$15,295 | 59,421 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2023 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 20,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents volume-weighted average price of sales of 752 shares of Company stock on November 14, 2023 at prices ranging from $794.03 to $794.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents volume-weighted average price of sales of 347 shares of Company stock on November 14, 2023 at prices ranging from $795.02 to $795.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents volume-weighted average price of sales of 204 shares of Company stock on November 14, 2023 at prices ranging from $797.09 to $797.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents volume-weighted average price of sales of 1,614 shares of Company stock on November 14, 2023 at prices ranging from $798.00 to $798.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents volume-weighted average price of sales of 1,601 shares of Company stock on November 14, 2023 at prices ranging from $799.00 to $799.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Represents volume-weighted average price of sales of 382 shares of Company stock on November 14, 2023 at prices ranging from $800.31 to $800.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
Represents volume-weighted average price of sales of 877 shares of Company stock on November 14, 2023 at prices ranging from $801.01 to $801.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F9
Represents volume-weighted average price of sales of 347 shares of Company stock on November 14, 2023 at prices ranging from $802.17 to $802.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F10
Represents volume-weighted average price of sales of 330 shares of Company stock on November 14, 2023 at prices ranging from $803.18 to $803.69. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.